The significance of clinical and morphological characteristics of spinal cord astrocytomas in the choice of surgical tactics

Authors

DOI:

https://doi.org/10.30978/GS-2024-2-27

Keywords:

intramedullary spinal cord astrocytomas, surgical treatment, neurological symptoms

Abstract

Objective —  to determine the factors affecting the dynamics of the neurological status in the postoperative period in patients with intramedullary spinal cord astrocytomas (SCA) in order to improve the results of their surgical treatment.

Materials and methods. Between 2010 and 2019, we conducted a retrospective study on the surgical treatment outcomes of 39 SCA patients operated on at the SI “Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine”. The age of the patients ranged from 19 to 67 years, with an average age of 41.4 years. Out of the total, 25 patients (64%) were men and 14 patients (36%) were women. We observed cervical localization in 11 (28%) clinical cases, thoracic localization in 25 (64%), and conus medullaris in 3 (8%). All patients underwent a comprehensive clinical and instrumental examination using magnetic resonance imaging with intravenous enhancement, computed tomography, and spondylography. The dynamics of neurological symptoms were evaluated using the modified McCormick before surgery, at the time of the patient’s hospital discharge, and during follow‑up examinations.

Results. Total removal of SCA was performed in 7 (18%) patients, subtotal in 25 (64%), and partial in 7 (18%). Pilocytic astrocytoma (PA) (World Health Organisation (WHO) grade I) was detected in 19 (49%) patients, diffuse astrocytoma (DA) (WHO grade II) in 17 (43%), and anaplastic astrocytoma (AA) (WHO grade III) in 3 (7%). Partial regression of neurological symptoms was noted in 29 (74%) patients, the neurological status remained at the preoperative level in 6 (15%) patients, and a slight increase in the neurological deficit was noted in 4 (10%) patients. Age <60 years is significantly more frequently associated with the growth of PA, while age >60 years is significantly more frequently associated with the growth of AA. The duration of anamnesis (< 1 year and >1 year) and the degree of radicality of the operation were identified as significant factors that can influence the neurological status in the late postoperative period, mainly in patients with PA and DA. However, such factors as tumour location and the degree of infiltration of nearby structures are not statistically significant. AA is associated with an unfavourable prognosis across all important criteria.

Conclusions. The most important determinants of SCA prognosis are preoperative and postoperative neurological condition, resection extent, and histological grade. Patients with minor neurological damage at the time of surgery, those under the age of 60, and those with highly differentiated SCA had the greatest surgical treatment outcomes. Assessment of the preoperative neurological status and determination of the histological type of the tumour are important factors in choosing the optimal surgical tactics, which сan improve treatment outcomes and the quality of life in SCA patients.

 

Author Biographies

O. I. Troyan, Bogomolets National Medical University, Kyiv

к. мед. н., доцент, доцент кафедри нейрохірургії

A. V. Muravskiy, Shupyk National Healthcare University of Ukraine, Kyiv

Doctor of Medical Sciences, Prof., Prof. of the Department of Neurosurgery

M. O. Marushchenko, Bogomolets National Medical University, Kyiv

MD, PhD, Assoc. Prof. of the Department of Neurosurgery

M. V. Khyzhnyak, SI «Romodanov Neurosurgery Institute of NAMS of Ukraine», Kyiv

Doctor of Medical Sciences, Head of the Department of Miniinvasive and Laser Spinal Neurosurgery

References

Anghileri E, Broggi M, Mazzapicchi E, et al. Therapeutic approaches in adult primary spinal cord astrocytoma: a systematic review. Cancers (Basel). 2022 Mar 2;14(5):1292. http://doi.org/10.3390/cancers14051292. PMID: 35267601; PMCID: PMC8909513.

Azad TD, Pendharkar AV, Pan J, et al. Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis. J Neurosurg Pediatr. 2018 Oct;22(4):404-10. http://doi.org/10.3171/2018.4.PEDS17587. Epub 2018 Jul 20. PMID: 30028275.

Benes V 3rd, Barsa P, Benes V Jr, Suchomel P. Prognostic factors in intramedullary astrocytomas: a literature review. Eur Spine J. 2009 Oct;18(10):1397-422. http://doi.org/10.1007/s00586-009-1076-8. Epub 2009 Jun 28. PMID: 19562388; PMCID: PMC2899373.

Campello C, Tabouret E, Chinot O. Challenges in diagnosis and management of adult spinal cord gliomas. Rev Neurol (Paris). 2021 May;177(5):515-23. http://doi.org/10.1016/j.neurol.2021.02.384. Epub 2021 Apr 23. PMID: 33896651.

Cerretti G, Pessina F, Franceschi E, et al. Spinal ependymoma in adults: from molecular advances to new treatment perspectives. Front Oncol. 2023 Nov 24;13:1301179. http://doi.org/10.3389/fonc.2023.1301179. PMID: 38074692; PMCID: PMC10704349.

Chai RC, Zhang YW, Liu YQ, et al. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation. Acta Neuropathol Commun. 2020 Mar 30;8(1):40. http://doi.org/10.1186/s40478-020-00913-w. PMID: 32228694; PMCID: PMC7106747.

Das JM, Hoang S, Mesfin FB. Intramedullary spinal cord tumors. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. PMID: 28723060.

Fakhreddine MH, Mahajan A, Penas-Prado M, et al. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol. 2013 Apr;15(4):406-12. http://doi.org/10.1093/neuonc/nos309. Epub 2013 Jan 14. PMID: 23322747; PMCID: PMC3607259.

Hersh AM, Jallo GI, Shimony N. Surgical approaches to intramedullary spinal cord astrocytomas in the age of genomics. Front Oncol. 2022 Sep 6;12:982089. http://doi.org/10.3389/fonc.2022.982089. PMID: 36147920; PMCID: PMC9485889.

Hussain I, Parker WE, Barzilai O, Bilsky MH. Surgical management of intramedullary spinal cord tumors. Neurosurg Clin N Am. 2020 Apr;31(2):237-49. http://doi.org/10.1016/j.nec.2019.12.004. Epub 2020 Jan 31. PMID: 32147015.

Jiang Y, Lv L, Yin S, Zhou P, Jiang S. Primary spinal pilocytic astrocytoma: clinical study with long-term follow-up in 16 patients and a literature review. Neurosurg Rev. 2020 Apr;43(2):719-27. http://doi.org/10.1007/s10143-019-01109-0. Epub 2019 May 16. PMID: 31098788.

Kandemirli SG, Reddy A, Hitchon P, Saini J, Bathla G. Intramedullary tumours and tumour mimics. Clin Radiol. 2020 Nov;75(11):876.e17-876.e32. http://doi.org/10.1016/j.crad.2020.05.010. Epub 2020 Jun 23. PMID: 32591229.

Khalid S, Kelly R, Carlton A, et al. Adult intradural intramedullary astrocytomas: a multicenter analysis. J Spine Surg. 2019 Mar;5(1):19-30. http://doi.org/10.21037/jss.2018.12.06. PMID: 31032435; PMCID: PMC6465470.

Knafo S, Aghakhani N, David P, Parker F. Management of intramedullary spinal cord tumors: A single-center experience of 247 patients. Rev Neurol (Paris). 2021 May;177(5):508-14. http://doi.org/10.1016/j.neurol.2020.07.014. Epub 2020 Oct 13. PMID: 33066996.

Lebrun L, Meléndez B, Blanchard O, et al. Clinical, radiological and molecular characterization of intramedullary astrocytomas. Acta Neuropathol Commun. 2020 Aug 8;8(1):128. http://doi.org/10.1186/s40478-020-00962-1. PMID: 32771057; PMCID: PMC7414698.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. http://doi.org/10.1007/s00401-016-1545-1. Epub 2016 May 9. PMID: 27157931.

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021 Aug 2;23(8):1231-51. http://doi.org/10.1093/neuonc/noab106. PMID: 34185076; PMCID: PMC8328013.

Manzano G, Green B, Vanni S, et al. Contemporary management of adult intramedullary spinal tumors — pathology and neurological outcomes related to surgical resection. Spinal Cord. 2008;46:540-6. https://doi.org/10.1038/sc.2008.51.

McFaline-Figueroa JR. Spinal cord neoplasms. Continuum (Minneap Minn). 2024 Feb 1;30(1):99-118. http://doi.org/10.1212/CON.0000000000001375. PMID: 38330474.

Merhemic Z, Stosic-Opincal T, Thurnher MM. Neuroimaging of spinal tumors. Magn Reson Imaging Clin N Am. 2016 Aug;24(3):563-79. http://doi.org/10.1016/j.mric.2016.04.007. PMID: 27417401.

Nagoshi N, Tsuji O, Suzuki S, et al. Clinical outcomes and a therapeutic indication of intramedullary spinal cord astrocytoma. Spinal Cord. 2022 Mar;60(3):216-22. http://doi.org/10.1038/s41393-021-00676-8. Epub 2021 Jul 26. PMID: 34312493.

Ottenhausen M, Ntoulias G, Bodhinayake I, et al. Intradural spinal tumors in adults-update on management and outcome. Neurosurg Rev. 2019 Jun;42(2):371-88. http://doi.org/10.1007/s10143-018-0957-x. Epub 2018 Feb 17. PMID: 29455369.

Pojskić M, Rotim K, Splavski B, Arnautović KI. Microsurgical management of low-grade spinal cord astrocytoma in adults: a personal case series report and brief literature review. Acta Clin Croat. 2020 Sep;59(3):505-12. http://doi.org/10.20471/acc.2020.59.03.15. PMID: 34177061; PMCID: PMC8212640.

Rashad S, Elwany A, Farhoud A. Surgery for spinal intramedullary tumors: technique, outcome and factors affecting resectability. Neurosurg Rev. 2018 Apr;41(2):503-11. http://doi.org/10.1007/s10143-017-0879-z. Epub 2017 Jul 17. PMID: 28717891.

Rijs K, Klimek M, Scheltens-de Boer M, Biesheuvel K, Harhangi BS. Intraoperative neuromonitoring in patients with intramedullary spinal cord tumor: a systematic review, meta-analysis, and case series. World Neurosurg. 2019 May;125:498-510.e2. http://doi.org/10.1016/j.wneu.2019.01.007. Epub 2019 Jan 17. PMID: 30659972.

Rudà R, Bruno F, Pellerino A, Soffietti R. Ependymoma: evaluation and management updates. Curr Oncol Rep. 2022 Aug;24(8):985-93. http://doi.org/10.1007/s11912-022-01260-w. Epub 2022 Apr 6. PMID: 35384591; PMCID: PMC9249684.

Shankar GM, Lelic N, Gill CM, et al. BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology. Acta Neuropathol. 2016 Jan;131(1):147-50. http://doi.org/10.1007/s00401-015-1492-2. PMID: 26487540; PMCID: PMC4698284.

Shao J, Jones J, Ellsworth P, et al. A comprehensive epidemiological review of spinal astrocytomas in the United States. J Neurosurg Spine. 2020 Nov 6;34(2):303-9. http://doi.org/10.3171/2020.6.SPINE191532. PMID: 33157530.

Sykes DAW, Waguia R, Abu-Bonsrah N, et al. Associations between urbanicity and spinal cord astrocytoma management and outcomes. Cancer Epidemiol. 2023 Oct;86:102431. http://doi.org/10.1016/j.canep.2023.102431. Epub 2023 Jul 19. PMID: 37478632.

Teng YD, Abd-El-Barr M, Wang L, Hajiali H, Wu L, Zafonte RD. Spinal cord astrocytomas: progresses in experimental and clinical investigations for developing recovery neurobiology-based novel therapies. Exp Neurol. 2019 Jan;311:135-47. http://doi.org/10.1016/j.expneurol.2018.09.010. Epub 2018 Sep 21. PMID: 30243796.

Tobin MK, Geraghty JR, Engelhard HH, Linninger AA, Mehta AI. Intramedullary spinal cord tumors: a review of current and future treatment strategies. Neurosurg Focus. 2015 Aug;39(2):E14. http://doi.org/10.3171/2015.5.FOCUS15158. PMID: 26235012.

Verla T, Fridley JS, Khan AB, Mayer RR, Omeis I. Neuromonitoring for intramedullary spinal cord tumor surgery. World Neurosurg. 2016 Nov;95:108-16. http://doi.org/10.1016/j.wneu.2016.07.066. Epub 2016 Jul 26. PMID: 27474459.

Villanueva-Castro E, Meraz-Soto JM, Hernández-Dehesa IA, Tena-Suck ML, Hernández-Reséndiz R, Mateo-Nouel EJ, Ponce-Gómez JA, Arriada-Mendicoa JN. Spinal Ependymomas: An Updated WHO Classification and a Narrative Review. Cureus. 2023 Nov 20;15(11):e49086. http://doi.org/10.7759/cureus.49086. PMID: 38125233; PMCID: PMC10731541.

Wang YZ, Zhang YW, Liu WH, et al. Spinal cord diffuse midline gliomas with H3 K27m-mutant: clinicopathological features and prognosis. Neurosurgery. 2021 Jul 15;89(2):300-7. http://doi.org/10.1093/neuros/nyab174. PMID: 34015818.

Wen PY, Packer RJ. The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications. Neuro Oncol. 2021 Aug 2;23(8):1215-7. http://doi.org/10.1093/neuonc/noab120. PMID: 34185090; PMCID: PMC8328017.

Downloads

Published

2024-06-30

How to Cite

1.
Troyan O, Muravskiy A, Marushchenko M, Khyzhnyak M. The significance of clinical and morphological characteristics of spinal cord astrocytomas in the choice of surgical tactics. ЗХ [Internet]. 2024Jun.30 [cited 2024Oct.18];(2):27-3. Available from: http://generalsurgery.com.ua/article/view/308062

Issue

Section

Original Research